杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2010/10/18 | 1,259 | 1,272 | 1,255 | 1,264 | -3 | -0.2% | 164,000 |
2010/10/15 | 1,285 | 1,285 | 1,263 | 1,267 | -15 | -1.2% | 150,000 |
2010/10/14 | 1,285 | 1,289 | 1,272 | 1,282 | +11 | +0.9% | 200,000 |
2010/10/13 | 1,265 | 1,280 | 1,258 | 1,271 | +6 | +0.5% | 192,000 |
2010/10/12 | 1,307 | 1,307 | 1,261 | 1,265 | -31 | -2.4% | 186,000 |
2010/10/08 | 1,312 | 1,313 | 1,294 | 1,296 | -9 | -0.7% | 260,000 |
2010/10/07 | 1,301 | 1,315 | 1,298 | 1,305 | ±0 | ±0% | 220,000 |
2010/10/06 | 1,317 | 1,320 | 1,302 | 1,305 | -15 | -1.1% | 238,000 |
2010/10/05 | 1,304 | 1,323 | 1,300 | 1,320 | +14 | +1.1% | 151,000 |
2010/10/04 | 1,348 | 1,348 | 1,296 | 1,306 | -44 | -3.3% | 385,000 |
2010/10/01 | 1,310 | 1,360 | 1,308 | 1,350 | +53 | +4.1% | 580,000 |
2010/09/30 | 1,299 | 1,306 | 1,295 | 1,297 | -7 | -0.5% | 249,000 |
2010/09/29 | 1,295 | 1,306 | 1,294 | 1,304 | -3 | -0.2% | 300,000 |
2010/09/28 | 1,295 | 1,312 | 1,289 | 1,307 | -28 | -2.1% | 439,000 |
2010/09/27 | 1,348 | 1,353 | 1,310 | 1,335 | -31 | -2.3% | 656,000 |
2010/09/24 | 1,330 | 1,368 | 1,327 | 1,366 | +37 | +2.8% | 526,000 |
2010/09/22 | 1,310 | 1,333 | 1,295 | 1,329 | -39 | -2.9% | 1,358,000 |
2010/09/21 | 1,447 | 1,459 | 1,357 | 1,368 | +161 | +13.3% | 2,148,000 |
2010/09/17 | 1,206 | 1,213 | 1,201 | 1,207 | +11 | +0.9% | 175,000 |
2010/09/16 | 1,198 | 1,201 | 1,185 | 1,196 | +1 | +0.1% | 131,000 |
2010/09/15 | 1,178 | 1,204 | 1,175 | 1,195 | +10 | +0.8% | 141,000 |
2010/09/14 | 1,189 | 1,193 | 1,181 | 1,185 | -7 | -0.6% | 102,000 |
2010/09/13 | 1,212 | 1,212 | 1,189 | 1,192 | -23 | -1.9% | 123,000 |
2010/09/10 | 1,209 | 1,226 | 1,204 | 1,215 | +5 | +0.4% | 159,000 |
2010/09/09 | 1,213 | 1,213 | 1,199 | 1,210 | +13 | +1.1% | 200,000 |
2010/09/08 | 1,201 | 1,205 | 1,176 | 1,197 | -19 | -1.6% | 245,000 |
2010/09/07 | 1,212 | 1,216 | 1,197 | 1,216 | -8 | -0.7% | 200,000 |
2010/09/06 | 1,182 | 1,225 | 1,180 | 1,224 | +30 | +2.5% | 301,000 |
2010/09/03 | 1,184 | 1,199 | 1,184 | 1,194 | +5 | +0.4% | 115,000 |
2010/09/02 | 1,186 | 1,194 | 1,177 | 1,189 | -4 | -0.3% | 166,000 |
2010/09/01 | 1,200 | 1,206 | 1,180 | 1,193 | -13 | -1.1% | 160,000 |
2010/08/31 | 1,238 | 1,239 | 1,201 | 1,206 | -33 | -2.7% | 181,000 |
2010/08/30 | 1,237 | 1,244 | 1,231 | 1,239 | +21 | +1.7% | 232,000 |
2010/08/27 | 1,212 | 1,220 | 1,203 | 1,218 | +6 | +0.5% | 247,000 |
2010/08/26 | 1,190 | 1,215 | 1,186 | 1,212 | +34 | +2.9% | 299,000 |
2010/08/25 | 1,187 | 1,187 | 1,171 | 1,178 | ±0 | ±0% | 270,000 |
2010/08/24 | 1,155 | 1,182 | 1,154 | 1,178 | +23 | +2% | 195,000 |
2010/08/23 | 1,153 | 1,161 | 1,153 | 1,155 | +7 | +0.6% | 155,000 |
2010/08/20 | 1,157 | 1,165 | 1,147 | 1,148 | -9 | -0.8% | 203,000 |
2010/08/19 | 1,158 | 1,161 | 1,149 | 1,157 | -5 | -0.4% | 210,000 |
2010/08/18 | 1,171 | 1,174 | 1,153 | 1,162 | +3 | +0.3% | 157,000 |
2010/08/17 | 1,159 | 1,164 | 1,148 | 1,159 | -3 | -0.3% | 132,000 |
2010/08/16 | 1,143 | 1,163 | 1,143 | 1,162 | +7 | +0.6% | 123,000 |
2010/08/13 | 1,148 | 1,160 | 1,139 | 1,155 | +14 | +1.2% | 135,000 |
2010/08/12 | 1,138 | 1,145 | 1,127 | 1,141 | -4 | -0.3% | 160,000 |
2010/08/11 | 1,155 | 1,156 | 1,141 | 1,145 | -22 | -1.9% | 125,000 |
2010/08/10 | 1,184 | 1,184 | 1,165 | 1,167 | -8 | -0.7% | 154,000 |
2010/08/09 | 1,182 | 1,190 | 1,168 | 1,175 | -16 | -1.3% | 272,000 |
2010/08/06 | 1,172 | 1,204 | 1,172 | 1,191 | +20 | +1.7% | 260,000 |
2010/08/05 | 1,162 | 1,188 | 1,159 | 1,171 | +22 | +1.9% | 307,000 |
3451~
3500
件表示中 / 3585件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 149,100円 | +3.2% | +4.5% | 3.49% | 17.13倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ゼリア新薬 | 222,100円 | +13.6% | +29.2% | 2.07% | 11.52倍 | 1.11倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ネクセラファーマ | 113,700円 | +197.7% | - | 0.00% | 46.47倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
JCRファーマ | 69,600円 | -3.7% | -36.7% | 2.87% | 22.92倍 | 1.50倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
栄研化 | 210,100円 | +0.4% | -8.4% | 2.52% | 27.77倍 | 1.58倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム